Emerging Company Profile

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Rome: tackling repeat DNA for cancer, autoimmunity</h1><h2 class="title-bottom webtitle">Rome launches with $50M series A round to leverage repeat biology</h2><div class="byline">Sandi Wong, Assistant Editor</div><div class="date"></div></div></div></div>

Rome: tackling repeat DNA for cancer, autoimmunity

GV-incubated Rome debuts with $50M series A and aims to regulate repeat DNA, RNA for cancer, autoimmune diseases.

Rome launches with $50M series A round to leverage repeat biology

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><br/><center><span style="font-size:1.75rem;font-weight:500;">Access this Article</span></center>